Does the company offer OEM or ODM services?

Yes, the company offers both OEM and ODM services supported by 370 R&D engineers.

What are the payment terms?

Accepted payment terms include LC, T/T, and D/P.

What is the average lead time for orders?

The average lead time is 1-3 months for both peak and off-peak seasons.

High Quality of Ampicillin and Cloxacillin Sodium Capsules

Name: High Quality of Ampicillin and Cloxacillin Sodium Capsules
Brand: Reyoung Pharmaceutical Co., Ltd.
SKU: 1947391032

Shandong, ChinaReyoung Pharmaceutical Co., Ltd.

Negotiable

10,000 box

Product profile

Customization

Available

Transport Package

10capsules/Blister

Specification

50*38*36 CM

Model NO.

250mg; 500mg

Trademark

Reyoung

Origin

China

Production Capacity

2, 000, 000, 000 Per Year

Key features

Broad Clinical Indications: Treats respiratory, urinary, meningitis, salmonella infections, endocarditis, and prevents neonatal group B strep.

WHO Essential Medicine: Listed on WHO Model List of Essential Medicines for basic public health systems globally.

Low Toxicity Profile: Features very low toxicity and low incidence of adverse reactions compared to alternatives.

Multiple Administration Routes: Can be administered orally, intramuscularly, and intravenously for flexible treatment options.

Comprehensive GMP Certification: All workshops passed Chinese GMP; company passed PIC/S, TFDA, NAFDAC, and other international audits.

Global Market Presence: Products exported to over 70 countries and NGOs with 160+ representative offices in China.

OEM and ODM Services: Offers professional OEM and ODM services with 370 R&D engineers supporting customization.

Established Manufacturer: Reyoung Pharmaceutical established in 1966 with 50 years of innovation and 3 factory sites.

Company profile

Reyoung Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2020-10-13 CertifiedNearest Port: Qingdao PortAverage Response Time: >24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryReyoung Pharmaceutical Co., Ltd. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The available information identifies it as a pharmaceutical manufacturer supplying injectable antibiotics, oral solid medicines, veterinary cefotaxime sodium sterile, and lyophilized products. It reports more than 10 production lines, 370 years of combined R&D engineer experience, 50 quality-control staff, and ISO9001, ISO14001, and ISO45001 certifications. Export sales represent 31%–40% of total sales, with exporting reported since 2020 in one record and since 1998 in the company description, creating a discrepancy. Trade records show limited documented transactions and associated buyers in Bolivia, India, and Vietnam. Evidence is insufficient to assess after-sales service, financial credibility, customization, or verified customer performance comprehensively.

Supplier typeThe supplier is identified as a limited company and pharmaceutical manufacturer based in Shandong, China. Its stated products include injectable cephalosporins and penicillins, oral solid medicines, lyophilized products, and veterinary medicines, indicating a combined manufacturing and commercial business profile.

CertificationsThe supplier reports ISO9001:2015, ISO14001:2015, and ISO45001:2016 management-system certificates, along with cGMP, PIC/S, and ANVISA GMP holdings. These claims directly support established quality, environmental, occupational-safety, and pharmaceutical GMP capability, although certificate validity and scope are not independently shown.

R&D capabilityThe supplier reports 370 years of total R&D engineer experience and offers multiple dosage forms and pharmaceutical categories, including lyophilized products and injectable antibiotics. These details support R&D resources and product-development breadth, but no information confirms proprietary technologies, new product launches, patents, or development outcomes.

Production capacityProduction capability is supported by 4,950 employees, more than 10 production lines, pharmaceutical manufacturing descriptions, and product records for injectable antibiotics and veterinary cefotaxime sodium sterile. The plant-area entry is recorded as 0.0m², which is unusable or inconsistent data, so facility scale cannot be confirmed from that field.

Client casesTrade-related records associate the supplier with buyers in Bolivia, India, and Vietnam and show documented transactions for oral rehydration products, cefotaxime acid, and ceftriaxone sodium for injection. The records show some international commercial activity, but the number of stated transactions is limited and no customer testimonials, repeat-order evidence, or performance evaluations are provided.

Product Q&A

Q:What infections does Ampicillin treat?

It treats respiratory tract infections, urinary tract infections, meningitis, salmonella infections, and endocarditis, and prevents group B streptococcal infection in neonates.

Q:How can Ampicillin be administered?

Ampicillin can be administered orally, intramuscularly, and intravenously.

Q:Is this product listed on the WHO Essential Medicines List?

Yes, the drug is listed on the World Health Organization Model List of Essential Medicines.

Q:What are the safety and toxicity levels?

The product has very low toxicity and a low incidence of adverse reactions, though large intravenous doses should be avoided in patients with severely reduced renal function.

Q:What certifications does the manufacturer hold?

All workshops passed Chinese GMP, and the company passed international audits including PIC/S GMP, TFDA, NAFDAC, and others.